Strattice Reconstructive Tissue Matrix Bps
Payments companies reported to CMS as associated with Strattice Reconstructive Tissue Matrix Bps. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Strattice Reconstructive Tissue Matrix Bps, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Strattice Reconstructive Tissue Matrix Bps
These are the largest totals companies reported as associated with Strattice Reconstructive Tissue Matrix Bps. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Martindale | Portland, OR | Surgery | $164,862.89 |
| Casey Thomas | Las Vegas, NV | Surgical Critical Care | $125,807.02 |
| Omar Guerra | Saint Louis, MO | Surgery | $99,913.09 |
| Scot Glasberg | New York, NY | Plastic Surgery | $86,207.03 |
| Vedra Augenstein | Charlotte, NC | Surgery | $86,187.00 |
| Maurice Nahabedian | Mc Lean, VA | Plastic and Reconstructive Surgery | $77,262.78 |
| Parag Bhanot | Washington, DC | Surgery | $70,588.18 |
| Michael Edwards | Las Vegas, NV | Plastic Surgery | $68,579.04 |
| Nicholas Clavin | Charlotte, NC | Plastic Surgery | $65,816.27 |
| Vahagn Nikolian | Portland, OR | Surgery | $53,784.36 |
Prescribed Strattice Reconstructive Tissue Matrix Bps?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.